Advertisement

Related Videos

Amit Sanyal, MD: A Clinician’s Perspective

Issues in Oncology

The ASCO Post Staff

Deborah Schrag, MD, MPH, on Clinical Trial Design: Statistical Options and Challenges

Deborah Schrag, MD, MPH, of Dana-Farber Cancer Institute, offers her perspective on near-equivalence, Bayesian noninferiority, and the value of cancer drug optimization.

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Opening Session Panel Discussion

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Advertisement

Advertisement




Jul
12
Today In Oncology
New Research Offers Reassurance About Localized Prostate Cancer Prognosis
Avelumab Plus Cetuximab in Advanced Cutaneous Squamous Cell Carcinoma
Surgery vs Ablation in Small Hepatocellular Carcinoma
Chemoimmunotherapy for Advanced BTC 3-Year Overall Survival Update From the TOPAZ Trial
Optimizing the CAR to the Disease in B-Cell Malignancies
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo